Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Progesterone receptor (PROGINS) polymorphism and the risk of ovarian cancer.

Steroids - 1 Jul 2008

Leite Daniela B, Junqueira Michele G, de Carvalho Cristina V, Massad-Costa Ana M, Gonçalves Wagner J, Nicolau Sergio M, Lopes Luiz A F, Baracat Edmundo C, da Silva Ismael D C G

Abstract excerpt

The present case-control study evaluates the role of the progesterone receptor (PR) polymorphism known as PROGINS as a risk factor for ovarian cancer development and investigates the association between these genetic variants and clinical/pathologic variables of ovarian cancer. PROGINS polymorphism was examined, by polymerase chain reaction, in a total of 80 patients with ovarian cancer and 282 control subjects....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ovarian Neoplasms
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Genetic Predisposition to Disease

Share to Polymorphism, Genetic

Share to Receptors, Progesterone

Share to Risk Factors

Source

Identifiers

PMID: 18384825
DOI: 10.1016/j.steroids.2008.02.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Progesterone receptor (PROGINS) polymorphism and the risk of ovarian cancer.PMID 18384825Read ↗

Progesterone receptor (PROGINS) polymorphism and the risk of endometrial cancer development.Semantic proximity Read ↗

Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies.Semantic proximity Read ↗

Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives.Semantic proximity Read ↗

Analyze association of the progesterone receptor gene polymorphism PROGINS with ovarian cancer risk.Semantic proximity Read ↗

Genetics of endometriosis: a role for the progesterone receptor gene polymorphism PROGINS?Semantic proximity Read ↗

Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer.Semantic proximity Read ↗

The progesterone receptor PROGINS polymorphism is not related to oxidative stress factors in women with polycystic ovary syndrome.Semantic proximity Read ↗

Association of the progesterone receptor gene polymorphism (PROGINS) with endometriosis: a meta-analysis.Semantic proximity Read ↗

Molecular Evaluation of PROGINS Mutation in Progesterone Receptor Gene and Determination of its Frequency, Distribution Pattern and Association with Breast Cancer Susceptibility in Saudi Arabia.Semantic proximity Read ↗

The progesterone receptor gene polymorphism, PROGINS, may be a factor related to the development of uterine fibroids.Semantic proximity Read ↗

Association of the PROGINS PgR polymorphism with susceptibility to female reproductive cancer: A meta-analysis of 30 studies.Semantic proximity Read ↗

Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.